Munich - Delayed Quote • EUR Healwell AI Inc (6H90.MU) Follow Compare 1.3600 +0.0250 (+1.87%) As of 10:07:58 AM GMT+1. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations HEALWELL AI Announces Upsize in Bought Deal Offering to $55 Million NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX) (OTCQX:HWAIF), a data science and AI company focused on preventative care, is pleased to announce that it has entered into an amended agreement pursuant to which Eight Capital and Scotiabank, as lead underwriters and joint bookrunners, together with a syndicate of underwriters (collectively, the “Underwrite HEALWELL to Acquire Orion Health, Creating a Global Market Leader in Healthcare Data Interoperability & Artificial Intelligence, and Launches $50 Million Bought Deal Financing HEALWELL AI has entered into an agreement to acquire 100% of the shares of Auckland, New Zealand based Orion Health Holdings Limited (“Orion Health”), a subscription license and services revenue business serving marquee public sector clients globally with data interoperability and healthcare navigation products and services.The two organisations are perfectly aligned on a combined mission to revolutionize healthcare through AI and data-driven innovation positioning HEALWELL as a global leader in HEALWELL Acquires Control of Mutuo Health Solutions to Build Next Generation of AI-Powered Physician Co-Pilots HEALWELL has acquired a majority controlling interest in Mutuo Health Solutions, a Toronto-based medical artificial intelligence company focused on developing predictive clinical AI technology.Mutuo Health's AutoScribe platform is an advanced AI-powered ambient scribe solution that transcribes clinician-patient interactions into high-quality electronic medical records in real time using natural language processing and machine learning technology.AutoScribe's speech recognition capabilities, desi HEALWELL's VeroSource Solutions Provides Corporate Update Demonstrating Rapid Growth and Expansion Across Canadian Public Sector Clients More than 600,000 New Brunswick residents are now eligible to generate a Patient Summary on the VeroSource-built MyHealthNB digital front door. This year, MyHealthNB averaged over 35,000 unique monthly users in New Brunswick, reflecting 100% growth compared to 2023.The VeroSource-managed Saskatchewan Health Authority website was accessed by patients and providers over 1.3 million times in 2024, representing a 50% increase in traffic from the previous year.In addition to its successful implementa HEALWELL AI Appoints Beatrice York, Dr. Marcel Reichart, and Reeva Misra to Strategic Advisory Board HEALWELL AI announces the formation of a Strategic Advisory Board, designed to empower the Company's global growth initiatives and offer expert guidance on product development, ethical considerations related to use of AI, regulatory compliance, and market positioning.Beatrice York, Dr. Marcel Reichart and Reeva Misra have joined HEALWELL's Strategic Advisory Board, bringing expertise across international business, AI, healthcare, and technology with the goal to help the company realize potential Healwell AI Inc. (TSE:AIDX) Analysts Are Cutting Their Estimates: Here's What You Need To Know It's been a pretty great week for Healwell AI Inc. ( TSE:AIDX ) shareholders, with its shares surging 11% to CA$1.68 in... ROTH to Host 13th Annual Technology Conference at the Hard Rock Hotel in New York City Event to feature one-on-one meetings between institutional investors and senior management from over 110 companies across a variety of technology sub-sectorsNEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN -- Roth Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 13th Annual Roth Technology Conference on November 19-20, 2024, at the Hard Rock Hotel, 159 W 48th St, New York, NY 10036. The conference will provide pre-qualified institutional investors with the HEALWELL Reports Record Revenue and Increased Customer Activity from Pharmaceutical Partners in Q3-2024 HEALWELL achieved record quarterly revenue from continuing operations of $13.7 million in Q3-2024, 738% higher than the $1.6 million generated in Q3-2023 and 153% higher than the $5.4 million generated in Q2-2024.Quarterly revenues were driven by HEALWELL completing the acquisitions of BioPharma Services Inc. and VeroSource Solutions Inc. during Q3-2024.Management maintains a positive outlook and based on current M&A pipeline continues to expect to make further M&A announcements by year-end whic HEALWELL's Pentavere Receives Prestigious Prix Galien USA 2024 Award for Best Digital Health Startup for Its Contributions in AI for Life Sciences Industry The Prix Galien Award is among the global health innovation industry's most renowned honors, recognizing outstanding biomedical, medical, and technology achievements that improve the human condition and is considered the industry's equivalent of the Nobel Prize. Pentavere's DARWEN™ AI platform was awarded for its proven contribution in making healthcare more accessible and personalized for patients and for using various forms of AI including generative AI to help identify patients and detect dis HEALWELL Provides Corporate Update on Accelerating Commercialization and Expansion of Pharmaceutical Partnerships by Leveraging Its Best-in-Class Patient Identification Capabilities HEALWELL's AI and data science subsidiaries have executed 5 new Master Services Agreements ("MSA") with new pharmaceutical partners in Q3-2024; bringing the total number of MSAs with life sciences partners to 27, which includes 6 of the top 10 pharmaceutical companies in the world. HEALWELL's AI and data science subsidiaries generated patient identification revenue from 23 of these pharmaceutical partners in Q3-2024.HEALWELL subsidiary, Khure Health, has executed an MSA for patient identificatio HEALWELL AI to Announce Third Quarter 2024 Financial Results on November 12, 2024 HEALWELL AI to hold a conference call and simultaneous webcast on Tuesday, November 12, 2024, at 1:00 pm EST (10:00 am PST).Toronto, Ontario--(Newsfile Corp. - November 4, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce the Company will release its Fiscal Third Quarter 2024 financial results for the period ended September ... WELL Health and HEALWELL AI Expand Strategic Alliance Agreement to Develop an AI-Enhanced Clinical Trials Program to Accelerate Innovation and Improve Patient Outcomes WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on tech-enabling healthcare providers, and HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF) ("HEALWELL"), a healthcare technology company focused on AI and data science for preventative care, are jointly pleased to announce the expansion of their multi-year strategic alliance agreement that allows WELL and HEALWELL to launch and manage clinical trial sites at WELL clinic locations across Canada. Levera HEALWELL AI Announces Strategic Investment and Commercialization Agreement with Abstractive Health to Advance Generative AI-Powered Clinical Documentation Solutions HEALWELL AI completes a strategic investment in NY-based Abstractive Health, alongside lead investor Rho Capital Partners, to support the development of AI-driven clinical documentation technology.Concurrent with the investment, HEALWELL also entered into a commercial agreement with Abstractive Health that provides HEALWELL with exclusive distribution rights to the Canadian outpatient healthcare market.Abstractive Health's AI software leverages LLMs and other generative AI technology to automate HEALWELL AI to Present at the LD Micro Main Event XVII Participating in-person at the LD Micro Main Event XVII from October 28-30th at the Luxe Sunset Boulevard Hotel in Los AngelesToronto, Ontario--(Newsfile Corp. - October 18, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce that Dr. Alexander Dobranowski, CEO of HEALWELL, will be participating at the 17th Annual LD Micro Main Event ... 2024 Cantech Letter Investment Conference Announces Presenting Companies and Exclusive Networking Events Cantech announces its lineup of presenting companies for the 2024 Cantech Letter Investment Conference taking place on October 9, 2024 at the Arcadian Loft in Toronto, ONIn addition, Cantech is hosting several networking events including: TSX Cantech Welcome Reception, Cantech Conference Closing Reception, and El Mocambo After-PartyVancouver, British Columbia & Toronto, Ontario--(Newsfile Corp. - October 1, 2024) - Cantech Letter (the "Company" or "Cantech"), a Canadian online publication of tec HEALWELL AI to Present at the 2024 Cantech Letter Conference in Toronto, ON HEALWELL AI CEO, Dr. Alexander Dobranowski, to present live at 10:00 AM PT on Wednesday, October 9, 2024 Vancouver, British Columbia--(Newsfile Corp. - September 25, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), an AI and data science company focused on preventative care, is pleased to announce its participation at the upcoming Cantech Letter Investment Conference on Wednesday, October 9, 2024 in Toronto Ontario. Dr. Alexander Dobranowski, CEO of ... Institutions own 21% of Healwell AI Inc. (TSE:AIDX) shares but retail investors control 60% of the company Key Insights Healwell AI's significant retail investors ownership suggests that the key decisions are influenced by... BioPharma Services Announces Expansion into Late-Stage Patient Trials and Integration with HEALWELL's Artificial Intelligence Platform Capabilities to Become a Full-Service Next Generation CRO HEALWELL's subsidiary, BioPharma Services, is expanding into late-stage patient trials through the integration of Canadian Phase Onward, a dedicated clinical research site built within the framework of HEALWELL's Polyclinic Family and Specialty Medicine Facility.This strategic integration is a significant milestone, enhancing BioPharma's ability to manage clinical trials across all phases of drug development and making the business a full-service Contract Research Organization. The move also sup HEALWELL AI's Pentavere Nominated for 2024 Prix Galien Award, a Prestigious Award, for Its Contributions in AI for Life Sciences and Announces Participation at Key Medical Conferences Pentavere is nominated for a 2024 Prix Galien Award for its contributions in AI and data science benefiting the human condition. The award is offered by the Galien Foundation and considered the most prestigious of all honours in the life sciences and pharmaceutical industry which is regularly awarded to recipients who are believed to have had the greatest impact on human health. This is Pentavere AI's third Prix Galien nomination in 3 years for ... WELL Health's OceanMD and HEALWELL's Intrahealth Announce Partnership to Expand Access to eReferral Healthcare Solutions WELL Health subsidiary, OceanMD, and HEALWELL subsidiary, Intrahealth, announce a partnership to integrate OceanMD's leading eReferral system across Intrahealth's global network to enhance digital interoperability, streamline healthcare processes, and improve patient access to care.This collaboration enables HEALWELL's Intrahealth to make OceanMD's eReferral system, which currently supports 120,000 eReferrals and eConsults monthly, available to a wider range of healthcare facilities, benefiting Performance Overview Trailing total returns as of 12/23/2024, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return 6H90.MU S&P/TSX Composite index YTD +166.67% +17.37% 1-Year +172.00% +17.81% 3-Year +126.67% +16.75%